Zobrazeno 1 - 10
of 424
pro vyhledávání: '"Kalbakis, K."'
Autor:
Georgoulias, V. *, Bozionelou, V., Agelaki, S., Perraki, M., Apostolaki, S., Kallergi, G., Kalbakis, K., Xyrafas, A., Mavroudis, D.
Publikováno v:
In Annals of Oncology July 2012 23(7):1744-1750
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Boukovinas, I., Souglakos, J., Hatzidaki, D., Kakolyris, S., Ziras, N., Vamvakas, L., Polyzos, A., Geroyianni, A., Agelidou, A., Agelaki, S., Kalbakis, K., Kotsakis, A., Mavroudis, D., Georgoulias, V.
Publikováno v:
In Lung Cancer 2009 63(1):77-82
Germline BRCA1 and BRCA2 loss-of-function variants have been linked to increased breast and ovarian cancer risk, with more than 5,000 distinct pathogenic variants being reported worldwide. Among individuals of Greek descent, the BRCA1/2 variant spect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3beaf939f4d6a5128cef816e571d6989
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078244
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078244
Autor:
Mavroudis, D., Pappas, P., Kouroussis, C., Kakolyris, S., Agelaki, S., Kalbakis, K., Androulakis, N., Souglakos, J., Vardakis, N., Nikolaidou, M., Samonis, G., Marselos, M., Georgoulias, V. *
Publikováno v:
In Annals of Oncology February 2003 14(2):304-312
Background This study evaluated the safety and efficacy of nab-paclitaxel as second-line treatment in patients with advanced gastric adenocarcinoma. Methods Thirty-nine pretreated patients [33 with taxane-based regimens (docetaxel, cisplatin, and flu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b4343ff89413a2b0e1b26bc798357a46
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107987
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107987
Metastatic triple-negative breast cancer lacks a standard therapeutic strategy and represents an unmet need for novel therapies. We conducted a phase II study to evaluate the weekly paclitaxel/carboplatin/bevacizumab combination. Forty-six patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::154f4eda955cf10b9483a2991c16251b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086505
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086505
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours
Autor:
Androulakis, N, Kouroussis, C, Mavroudis, D, Kakolyris, S, Souglakos, J, Agelaki, S, Kalbakis, K, Malas, K, Pallis, A, Samonis, G, Georgoulias, V
Publikováno v:
In European Journal of Cancer October 2002 38(15):1992-1997
Autor:
Mavroudis, D *, Veslemes, M, Kouroussis, Ch, Tzanakis, N, Ferdoutsis, E, Toumbis, M, Ziotopoulos, P, Agelidou, M, Tselepatiotis, E, Kalbakis, K, Souglakos, J, Magkanas, E, Samonis, G, Georgoulias, V, Group, for the Hellenic Oncology Research
Publikováno v:
In Lung Cancer 2002 38(1):59-63
Autor:
Papakostas, P, Kouroussis, Ch, Androulakis, N, Samelis, G, Aravantinos, G, Kalbakis, K, Sarra, E, Souglakos, J, Kakolyris, S, Georgoulias, V
Publikováno v:
In European Journal of Cancer October 2001 37(15):1833-1838